Overview

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects

Status:
Completed

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

The objective of the study was to investigate the drug-drug interaction between LC15-0444 and metformin by comparing the pharmacokinetic/pharmacodynamic, safety, tolerability in healthy male subjets after oral administration concomitantly and each alone.

Phase:

Phase 1

Details

Lead Sponsor:

LG Life Sciences

Treatments:

Metformin